A team of researchers led by Caltech scientists have shown that nanoparticles can function to target tumors while avoiding adjacent healthy tissue in human cancer patients.
Bio & Medicine
Mar 21, 2016
0
40
Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block ...
Bio & Medicine
Jan 20, 2022
0
1205
A micro-sized polymeric net wrapping around brain tumors, just like a fishing net around a shoal of fish: this is microMESH, a new nanomedicine device capable of conforming around the surface of tumor masses and efficiently ...
Bio & Medicine
Apr 19, 2021
0
87
Scientists' inability to replicate research findings using mice and rats has contributed to mounting concern over the reliability of such studies.
Plants & Animals
Apr 28, 2014
0
0
Irradiation with fast protons is a more effective and less invasive cancer treatment than X-rays. However, modern proton therapy requires large particle accelerators, which has experts investigating alternative accelerator ...
Optics & Photonics
Mar 14, 2022
0
196
To design safe clinical trials, it is crucial to better understand and predict gene editing outcomes in preclinical studies. Bence György and collaborators have shown that adeno-associated viruses (AAVs) can stably integrate ...
Biotechnology
Oct 15, 2019
0
6
A technique developed by University of Texas at Dallas and UT Southwestern Medical Center researchers to deliver medication through the blood-brain barrier has shown promise in a preclinical study for treating glioblastoma, ...
Bio & Medicine
Oct 16, 2023
0
19
Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and improves the therapeutic efficacy of immune ...
Bio & Medicine
May 30, 2022
0
124
A study published in Pharmacological Research reveals the oligomeric molecular structure of the MOR-Gal1R complex, a component present in the brain which is involved in the analgesic and addictive effects of certain opioids. ...
Biochemistry
Jul 22, 2022
0
18
Recent research has identified MYT1 as a promising new therapeutic target for breast and gynecological cancer and discovered a series of novel, potent, and highly selective inhibitors specifically targeting MYT1.
Analytical Chemistry
Jan 19, 2024
0
37
